|
|
News Breaks
|
November 19, 2009
|
| 08:02 EDT |  | GTCB |
| theflyonthewall.com: | GTC Biotherapeutics receives extension from Nasdaq | | GTC Biotherapeutics has received from a NASDAQ Hearings Panel an extension to March 16, 2010 to regain compliance with the market value of listed securities requirement for continued listing on The NASDAQ Capital Market, as specified by NASDAQ Listing Rule 5550(b)(2). The Company’s common stock will continue to be listed on The NASDAQ Capital Market during the extension. GTC can satisfy the terms of the Panel’s decision by demonstrating a market value of listed securities of at least $35M for ten consecutive trading days prior to the end of the extension period. :theflyonthewall.com |
|
|
News For GTCB From The Last 14 Days Check below for free stories on GTCB the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
